FCGR2A and cancer: In such a context, high concentrations of sCXCR4-A after locoregional delivery could be relevant in immunotherapies of cancer cells with deregulated type I IFN signaling pathways55 because FcγR-mediated antibody-dependent cellular phagocytosis bypasses the need for canonical phagocytic determinants.